Sort
4,870 grants matching “glp 1”
Novel small-molecule TNF-a modulators as chemoprotective agents
$542,156Jiajiu Shaw · 21st Century Therapeutics, Inc. · R44 · FY2012 · CA
FOXL1 positive telocytes in intestinal development and homeostsis
$541,989Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2024 · DK
FOXL1 positive telocytes in intestinal development and homeostsis
$541,989Klaus H. Kaestner · University Of Pennsylvania · R01 · FY2025 · DK
XENIN-25: NOVEL REGULATOR OF INSULIN SECRETION AND B-CELL FUNCTION
$541,120Burton M Wice · Washington University · R01 · FY2010 · DK
Role of semaglutide in restoring ovulation in youth and adults with polycystic ovary syndrome
$541,072Melanie G Cree · University Of Colorado Denver · R01 · FY2023 · HD
Metabolic Functions of Pyruvate Kinase M2 in Pancreatic Beta-cells
$539,398Matthew J. Merrins · University Of Wisconsin-Madison · R01 · FY2024 · DK
Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for treatment of Sanfilippo Syndrome type B (Supplement)
$538,939Coy D Heldermon · University Of Florida · UG3 · FY2025 · NS
Development of PET imaging biomarkers to predict enhanced glioblastoma radiotherapy by a novel H-NOX oxygen carrier
$538,027Jonathan A Winger · Omniox, Inc. · R01 · FY2021 · CA
Parsing the central control of thirst and hunger using a rat model of diabetes insipidus
$537,476Derek Daniels · State University Of New York At Buffalo · R01 · FY2025 · DK
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
$537,464Michelle A Rudek · Johns Hopkins University · U24 · FY2020 · CA
Neuroprotective And Neurorestorative Signaling Mechanisms
$536,531Mark Mattson · National Institute On Aging · ZIA · FY2012 · AG
Preventing invasive prostate cancer
$535,783Raymond C Bergan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Parsing the central control of thirst and hunger using a rat model of diabetes insipidus
$535,735Derek Daniels · State University Of New York At Buffalo · R01 · FY2023 · DK
Novel drug combinations for the management of pain
$535,671Kenneth W Narducy · St. Charles Pharmaceuticals · R44 · FY2007 · NS
Safety and Efficacy of a Titratable External Shunt
$535,202Lucinda Camras · Camras Vision, Inc. · R44 · FY2018 · EY
Core B: PREVENT Product Development Core
$534,969Lisa C Rohan · University Of Louisville · U19 · FY2015 · AI
Twice-Weekly Subcutaneous Liposome Chelator to Treat Transfusional Iron Overload
$534,478Mark Eamon Hayes · Zoneone Pharma, Inc. · R44 · FY2015 · HD
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
$533,033Mark A Atkinson · University Of Florida · R01 · FY2021 · DK
Molecular mechanisms mediating metabolic benefits of glucagon-like peptide-1 receptor agonists
$532,979Julio E Ayala · Vanderbilt University · R01 · FY2025 · DK
Impact of diet composition during infancy on energy balance, satiety and growth
$532,267Julie A Mennella · Monell Chemical Senses Center · R01 · FY2013 · HD
Functional Brain Imaging and Appetite-Related Hormones Pre and Post Obesity Surge
$531,302Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2011 · DK
Functional Brain Imaging and Appetite-Related Hormones Pre and Post Obesity Surge
$531,302Allan Geliebter · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2012 · DK
Efficacy of Novel Melanocortin and Gut-peptide Dual Agonists for Childhood Obesity Treatment
$531,174Christian Ludwig Roth · Seattle Children'S Hospital · R21 · FY2024 · HD
Validation of an In Vitro Human Airway Model for Regulatory Toxicity Testing
$530,965Patrick J Hayden · Mattek Corporation · U44 · FY2018 · ES
Regulation of Net Hepatic Glucose Uptake in Vivo
$530,273Alan D Cherrington · Vanderbilt University · R01 · FY2008 · DK